EP2838544A4 - Poly(acrylate) polymers for in vivo nucleic acid delivery - Google Patents
Poly(acrylate) polymers for in vivo nucleic acid deliveryInfo
- Publication number
- EP2838544A4 EP2838544A4 EP12874655.9A EP12874655A EP2838544A4 EP 2838544 A4 EP2838544 A4 EP 2838544A4 EP 12874655 A EP12874655 A EP 12874655A EP 2838544 A4 EP2838544 A4 EP 2838544A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- acrylate
- poly
- polymers
- nucleic acid
- acid delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 Poly(acrylate) Polymers 0.000 title 2
- 238000001727 in vivo Methods 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 229920000058 polyacrylate Polymers 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F220/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
- C08F220/365—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate containing further carboxylic moieties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261625955P | 2012-04-18 | 2012-04-18 | |
| PCT/US2012/051973 WO2013158141A1 (en) | 2012-04-18 | 2012-08-23 | Poly(acrylate) polymers for in vivo nucleic acid delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2838544A1 EP2838544A1 (en) | 2015-02-25 |
| EP2838544A4 true EP2838544A4 (en) | 2015-10-14 |
Family
ID=52347562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12874655.9A Withdrawn EP2838544A4 (en) | 2012-04-18 | 2012-08-23 | Poly(acrylate) polymers for in vivo nucleic acid delivery |
Country Status (1)
| Country | Link |
|---|---|
| EP (1) | EP2838544A4 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090048410A1 (en) * | 2002-03-11 | 2009-02-19 | Wakefield Darren H | Membrane Active Heteropolymers |
| US20110207799A1 (en) * | 2010-02-24 | 2011-08-25 | Roche Madison Inc. | Compositions for Targeted Delivery of siRNA |
| WO2012083046A2 (en) * | 2010-12-17 | 2012-06-21 | Arrowhead Research Corporation | Galactose cluster-pharmacokinetic modulator targeting moiety for sirna |
-
2012
- 2012-08-23 EP EP12874655.9A patent/EP2838544A4/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090048410A1 (en) * | 2002-03-11 | 2009-02-19 | Wakefield Darren H | Membrane Active Heteropolymers |
| US20110207799A1 (en) * | 2010-02-24 | 2011-08-25 | Roche Madison Inc. | Compositions for Targeted Delivery of siRNA |
| WO2012083046A2 (en) * | 2010-12-17 | 2012-06-21 | Arrowhead Research Corporation | Galactose cluster-pharmacokinetic modulator targeting moiety for sirna |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO2013158141A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2838544A1 (en) | 2015-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231147A0 (en) | Poly(acrylate) polymers for in vivo nucleic acid delivery | |
| IL231146A0 (en) | Poly (vinyl ester) polymers for in vivo nucleic acid delivery | |
| SG11201405542UA (en) | Artificial nucleic acid molecules | |
| EP2809686A4 (en) | Cyclodextrin-based polymers for therapeutic delivery | |
| GB201201578D0 (en) | Polymer | |
| PH12013501775A1 (en) | Polymeric acid catalysts and uses thereof | |
| GB201215193D0 (en) | Order delivery system | |
| SG10201702125TA (en) | Syringe pump system | |
| EP2921506A4 (en) | Modified polymer | |
| IL235325A0 (en) | Nucleic acid extraction | |
| EP3065722A4 (en) | Nucleic acid nanostructures for in vivo agent delivery | |
| GB2513034B (en) | Polymer | |
| SG11201502386PA (en) | Polymerization process | |
| IL239223A0 (en) | Transdermal delivery system | |
| SG11201404892UA (en) | Polymer scaffolds for assay applications | |
| PL2866854T3 (en) | Polymers for use in methods | |
| SG11201406508UA (en) | Poly(acrylic acid) from bio-based acrylic acid and its derivatives | |
| SG11201502424XA (en) | Molecular genetic diagnostic system | |
| GB201411209D0 (en) | Polymer | |
| GB201219783D0 (en) | Soluble polymers | |
| SG11201501661YA (en) | Polymer composition | |
| SG11201408594RA (en) | Moisture-curable, amine-catalyzed surfur-containing polymer compositions | |
| IL226170A0 (en) | Compositions and methods for nanopolymer-based nucleic acid delivery | |
| SG10201609440WA (en) | Multi-additive delivery system | |
| EP2874940A4 (en) | Liquid delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140324 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150910 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08L 33/06 20060101AFI20150904BHEP |
|
| 17Q | First examination report despatched |
Effective date: 20170201 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20200303 |